Trial Profile
A Randomised Trial Investigating the Effect on Biochemical (PSA) Control and Survival of Different Durations of Adjuvant Androgen Deprivation in Association With Definitive Radiation Treatment for Localised Carcinoma of the Prostate.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Leuprorelin
- Indications Adenocarcinoma; Bone metastases; Fracture; Osteoporosis; Prostate cancer
- Focus Adverse reactions; Registrational
- Acronyms RADAR
- 15 Mar 2020 Results of ten years data were published in the International Journal of Radiation Oncology, Biology, Physics
- 19 Dec 2018 Results published in the Lancet Oncology
- 10 Oct 2017 Status changed from active, no longer recruiting to completed.